LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | R406 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3350 | 3846 | 0.8710 | 0.8444 |
Hs 578T | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 658 | 2505 | 3846 | 0.6513 | 0.5793 |
Hs 578T | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3688 | 3846 | 0.9591 | 0.9506 |
Hs 578T | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 658 | 1510 | 3846 | 0.3927 | 0.2673 |
Hs 578T | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 658 | 1114 | 3846 | 0.2897 | 0.1431 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3367 | 3846 | 0.8754 | 0.8497 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3115 | 3846 | 0.8101 | 0.7709 |
Hs 578T | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 658 | 3573 | 3846 | 0.9292 | 0.9145 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 658 | 913 | 3846 | 0.2374 | 0.0799 |
Hs 578T | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3357 | 3846 | 0.8728 | 0.8466 |
Hs 578T | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 658 | 1516 | 3846 | 0.3942 | 0.2691 |
Hs 578T | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3479 | 3846 | 0.9047 | 0.8851 |
Hs 578T | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3264 | 3846 | 0.8488 | 0.8176 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3710 | 3846 | 0.9646 | 0.9573 |
Hs 578T | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 658 | 3641 | 3846 | 0.9467 | 0.9357 |
Hs 578T | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3068 | 3846 | 0.7977 | 0.7559 |
Hs 578T | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3677 | 3846 | 0.9560 | 0.9470 |
Hs 578T | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3456 | 3846 | 0.8987 | 0.8778 |
Hs 578T | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3692 | 3846 | 0.9600 | 0.9518 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3756 | 3846 | 0.9766 | 0.9717 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 658 | 628 | 3846 | 0.1635 | -0.0093 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 658 | 602 | 3846 | 0.1567 | -0.0174 |
Hs 578T | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3057 | 3846 | 0.7950 | 0.7527 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 2999 | 3846 | 0.7798 | 0.7344 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 4002 | 3846 | 1.0406 | 1.0490 |